Source: International Congress 2019 – Basic research of airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Kononikhin (Moscow, Russian Federation), K. Fedorchenko (Moscow, Russian Federation), M. Kushaeva (Moscow, Russian Federation), E. Anaev (Moscow, Russian Federation), S. Mitrofanov (Moscow, Russian Federation), A. Ryabokon (Moscow, Russian Federation), I. Popov (Moscow, Russian Federation), V. Barmin (Moscow, Russian Federation), . Indeykina (Moscow, Russian Federation), O. Pikin (Moscow, Russian Federation), E. Nikolaev (Moscow, Russian Federation), S. Varfolomeev (Moscow, Russian Federation), A. Chuchalin (Moscow, Russian Federation). Lung disease diagnostic method based on proteomic analysis of exhaled breath condensate. 3583

Member's Comments

No comment yet.

Related content which might interest you: Diagnosis of lung diseases based on proteomic analysis of exhaled breath condensate Source: International Congress 2017 – Clinical problems in lung diseases Year: 2017 Is NMR-based metabolomic analysis of exhaled breath condensate accurate? Source: Eur Respir J 2011; 37: 468 Year: 2011 Is the analysis of torbamycin in exhaled breath condensate a diagnostic tool to monitor pulmonary drug deposition? Source: Eur Respir J 2004; 24: Suppl. 48, 386s Year: 2004 Metabolomic/proteomic analysis of biomarkers in exhaled breath condensates Source: Annual Congress 2008 - PG8 - Cellular and molecular technologies of today - treatments of tomorrow Year: 2008 SELDI-TOF MS for proteomic analysis of exhaled breath condensate from patients with pulmonary emphysema Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009 Metabolomic analysis of exhaled breath condensate in diagnostics of obstructive airway diseases Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Exhaled breath condensate biomarkers in COPD Source: Eur Respir J 2008; 32: 472-486 Year: 2008 The validation of assays used to measure biomarkers in exhaled breath condensate Source: Eur Respir J 2008; 32: 1408-1409 Year: 2008 Better characterization of local inflammation in COPD: detection of new biomarkers in exhaled breath condensate Source: Eur Respir J 2006; 28: Suppl. 50, 747s Year: 2006 Exhaled breath condensate: metabolomics Source: Eur Respir Monogr 2010; 49: 231-236 Year: 2010 Exhaled breath condensate sample collection: standards and open issues Source: Eur Respir Monogr 2010; 49: 152-161 Year: 2010 Early detection of lung cancer through analysis of VOC biomarkers in exhaled breath: The LuCID study. Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies Year: 2017 Standardization of collection of exhaled breath condensate (EBC) for disease markers in use of different condensers Source: Eur Respir J 2003; 22: Suppl. 45, 448s Year: 2003 Exhaled breath analysis by use of eNose technology: a novel diagnostic tool for interstitial lung disease Source: Eur Respir J, 57 (1) 2002042; 10.1183/13993003.02042-2020 Year: 2021 Changes in exhaled breath condensate in asthma and COPD: A full analysis of mass-spectra Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Phenotyping of COPD by integrated metabolomic profiling of exhaled breath condensate and peripheral blood Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Differential diagnosis between newly diagnosed asthma and COPD using exhaled breath condensate metabolomics: a pilot study Source: Eur Respir J, 51 (3) 1701825; 10.1183/13993003.01825-2017 Year: 2018 Reproducibility of exhaled breath condensate markers Source: Eur Respir J 2008; 32: Year: 2008 Validation of eicosanoid measurements in exhaled breath condensate Source: Eur Respir J 2002; 20: Suppl. 38, 422s Year: 2002 Metabonomics applied to exhaled breath condensate in childhood asthma Source: Eur Respir J 2006; 28: Suppl. 50, 123s Year: 2006